GenomeNet

Database: CarbBank
Entry: 17357 26394 34173 4652 691 692 693
LinkDB: 17357 26394 34173 4652 691 692 693
CC: CCSD:17357
AU: Kannagi R; Watanabe K; Hakomori S
TI: Isolation and purification of glycosphingolipids by high-performance
    liquid chromatography
CT: Methods Enzymol (1987) 138: 3-12 [PMID:3600327]
SC: x2
MT: glycolipid
MT: glycosphingolipid
AM: HPLC
SB: Hansen LBL
DA: 06-02-1994
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:26394
AU: Thorn JJ; Levery SB; Salyan MEK; Stroud MR; Cedergren B; Nilsson B;
    Hakomori S; Clausen H
TI: Structural characterization of X2 glycosphingolipid, its extended
    form, and its sialosyl derivatives: accumulation associated with the rare
    blood-group p phenotype
CT: Biochemistry (1992) 31: 6509-6517 [PMID:1378756]
SC: x2
BS: (CN) human, (GT) blood-group p, (OT) red blood cells
MT: glycolipid
MT: glycosphingolipid
SB: van Halbeek H
DA: 20-01-1993
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:34173
AU: King MJ
TI: Blood group antigens on human erythrocytes-distribution, structure
    and possible functions
CT: Biochim Biophys Acta (1994) 1197: 15-44 [PMID:8155690]
BS: (CN) human, (OT) erythrocyte
AN: x2 antigen
MT: glycolipid
MT: glycosphingolipid
NT: review article
SB: van Kuik A
DA: 12-12-1994
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:4652
AU: Mandrell RE; Apicella MA
TI: Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry
    and host-modification of LOS
CT: Immunobiology (1993) 187: 382-402 [PMID:8330904]
SC: 18
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 12-11-1993
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:691
AU: Kannagi R; Fukuda MN; Hakomori S
TI: A new glycolipid antigen isolated from human erythrocyte membranes
    reacting with antibodies directed to globo-N-tetraosylceramide (globoside)
CT: J Biol Chem (1982) 257: 4438-4442 [PMID:7068643]
BS: (CN) human, (OT) erythrocyte
MT: glycolipid
MT: glycosphingolipid
AM: GC-MS
SB: Karlsson KA
DA: 22-04-1989
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:692
AU: Kannagi R; Levine P; Watanabe K; Hakomori S
TI: Recent studies of glycolipid and glycoprotein profiles and
    characterization of the major glycolipid antigen in gastric cancer of a
    patient of blood-group genotype PP (Tja-) first studied in 1951
CT: Cancer Res (1982) 42: 5249-5254 [PMID:7139617]
SC: X2 component
BS: (CN) human, (OT) gastric tumor, (disease) cancer
MT: glycolipid
MT: glycosphingolipid
AM: MS
SB: Karlsson KA
DA: 22-04-1989
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:693
AU: Angstrom J; Karlsson H; Karlsson KA; Larson G; Nilson K
TI: GalNAc.beta.1-3 terminated glycosphingolipids of human erythrocytes
CT: Arch Biochem Biophys (1986) 251: 440-449 [PMID:3800377]
BS: (CN) human, (OT) erythrocyte
MT: glycolipid
MT: glycosphingolipid
AM: 1H-NMR
AM: GC
AM: MS
SB: Karlsson KA
DA: 22-04-1989
FC: cdace2f4
SI: CBank:16007
----------------
structure:

 b-D-GalpNAc-(1-3)-b-D-Galp-(1-4)-b-D-GlcpNAc-(1-3)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
DBGET integrated database retrieval system